123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias
- PMID: 26671107
- DOI: 10.1016/j.jns.2015.11.004
123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias
Abstract
Aim: To systematically review the utility of dopamine system imaging using 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies (DLB) and other dementia syndromes.
Methods: We searched MEDLINE, CENTRAL and ClinicalTrials.gov to identify studies reporting enough data to determine accuracy measure of 123I-FP-CIT SPECT in differentiating between DLB and other dementia syndromes. Studies including patients with Parkinson's disease or other parkinsonisms associated with abnormal DAT imaging were excluded. The methodological quality of studies was evaluated with QUADAS-2.
Results: Eight studies were included. Studies adopting a clinical diagnosis as a reference standard showed sensitivity and specificity values of DaTSCAN in differentiating between DLB and non-DLB dementia syndromes (all subtypes, AD and FTD) consistently higher than 80%, both considering a visual and a semiquantitative analysis. The meta-analyses from the three studies using a neuropathological reference standard yielded sensitivity and specificity values higher than those adopting a clinical diagnostic reference.
Conclusions: 123I-FP-CIT SPECT can represent an accurate method to differentiate between DLB and other dementia syndromes. However, most data in the literature derive from studies adopting the clinical diagnosis as the reference diagnostic standard and which are therefore intrinsically unable to demonstrate an accuracy of DAT imaging above that of careful clinical diagnosis alone. The very few studies providing information on the neuropathologic correlation for the DaTSCAN findings show however high sensitivity and specificity values, suggesting that SPECT scan is more accurate than clinical diagnosis and may prove useful in supporting the clinical diagnosis of DLB.
Keywords: 123I-FP-CIT single photon emission computed tomography; Alzheimer's disease; Dementia with Lewy bodies; Meta-analysis; Sensitivity; Specificity.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.Clin Nucl Med. 2015 Jan;40(1):e27-33. doi: 10.1097/RLU.0000000000000554. Clin Nucl Med. 2015. PMID: 25140560
-
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.Lancet Neurol. 2007 Apr;6(4):305-13. doi: 10.1016/S1474-4422(07)70057-1. Lancet Neurol. 2007. PMID: 17362834 Clinical Trial.
-
Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1063-70. doi: 10.1136/jnnp-2012-302577. Epub 2012 Aug 6. J Neurol Neurosurg Psychiatry. 2012. PMID: 22869921
-
Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies.Parkinsonism Relat Disord. 2012 Mar;18(3):225-9. doi: 10.1016/j.parkreldis.2011.09.015. Epub 2011 Oct 5. Parkinsonism Relat Disord. 2012. PMID: 21975260 Review.
-
[123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.Alzheimers Dement. 2012 Jan;8(1):74-83. doi: 10.1016/j.jalz.2011.08.003. Epub 2011 Oct 22. Alzheimers Dement. 2012. PMID: 22024052 Review.
Cited by
-
Visual versus semiquantitative analysis of 18F- fluorodeoxyglucose-positron emission tomography brain images in patients with dementia.World J Nucl Med. 2021 Jan 20;20(1):82-89. doi: 10.4103/wjnm.WJNM_53_18. eCollection 2021 Jan-Mar. World J Nucl Med. 2021. PMID: 33850493 Free PMC article.
-
Cerebrospinal Fluid, Imaging, and Physiological Biomarkers in Dementia With Lewy Bodies.Am J Alzheimers Dis Other Demen. 2019 Nov-Dec;34(7-8):421-432. doi: 10.1177/1533317519869700. Epub 2019 Aug 18. Am J Alzheimers Dis Other Demen. 2019. PMID: 31422676 Free PMC article. Review.
-
Neuroimaging in Lewy body dementia.J Neurol. 2019 Jan;266(1):1-26. doi: 10.1007/s00415-018-8892-x. Epub 2018 May 14. J Neurol. 2019. PMID: 29761296 Free PMC article. Review.
-
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017. Transl Neurodegener. 2017. PMID: 28360997 Free PMC article. Review.
-
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. J Neural Transm (Vienna). 2018. PMID: 29222591 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical